Status:

COMPLETED

Arginine Malaria Trial: Study of Adjunctive Arginine in Falciparum Malaria

Lead Sponsor:

Menzies School of Health Research

Collaborating Sponsors:

Wellcome Trust

National Health and Medical Research Council, Australia

Conditions:

Malaria, Falciparum

Eligibility:

All Genders

18-60 years

Phase:

PHASE1

PHASE2

Brief Summary

Acute falciparum malaria is associated with low plasma arginine and impaired nitric oxide (NO) production. Both are associated with poor outcome. This study will examine the safety and effect of escal...

Eligibility Criteria

Inclusion

  • Ages 18-60 years
  • P. falciparum parasitemia (1,000-100,000 parasites/ul).
  • Clinical syndrome consistent with malaria associated with documented fever (axillary temperature \> 38℃) or self-reported history of fever in the last 48 hours with no other cause present
  • Commenced oral quinine ≤ 18 hours prior to scheduled commencement of arginine
  • An indication for hospital admission (eg relative cannot look after/supervise treatment at home but not having any warning signs or severe malaria criteria in "exclusion criteria" below)
  • Informed consent obtained

Exclusion

  • Pregnancy or lactation
  • Mixed infection with P. falciparum and P. vivax
  • Warning signs of altered mental state and inability to sit unaided
  • Features of severe/complicated malaria
  • Diabetes
  • Systolic blood pressure (BP) \< 100 mmHg
  • Serious underlying disease (cardiac, hepatic, kidney)
  • Initial iSTAT test showing any of the following values:
  • glucose \< 4 mmol/L;
  • K+ ≥ 4.2 meq/L;
  • Cl- \> 106 meq/L;
  • HCO3- \< 20 meq/L.
  • Known allergy to L-arginine
  • Concurrent therapy with any of the following medications:
  • spironolactone;
  • oral nitrates;
  • phosphodiesterase inhibitor (eg sildenafil \[Viagra\]);
  • alpha-blocking antihypertensive agents (eg prazosin);
  • L-arginine.

Key Trial Info

Start Date :

February 1 2005

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 1 2007

Estimated Enrollment :

50 Patients enrolled

Trial Details

Trial ID

NCT00147368

Start Date

February 1 2005

End Date

December 1 2007

Last Update

June 2 2008

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

RSMM Hospital

Timika, Indonesia

Arginine Malaria Trial: Study of Adjunctive Arginine in Falciparum Malaria | DecenTrialz